ונקלקסטה 100 מג טבליות
abbvie biopharmaceuticals ltd, israel - venetoclax - טבליות מצופות פילם - venetoclax 100 mg - venetoclax
ונקלקסטה 100 מג טבליות
abbvie biopharmaceuticals ltd, israel - venetoclax - טבליות מצופות פילם - venetoclax 100 mg - venetoclax
ונקלקסטה 50 מג טבליות
abbvie biopharmaceuticals ltd, israel - venetoclax - טבליות מצופות פילם - venetoclax 50 mg - venetoclax
ונקלקסטה 50 מג טבליות
abbvie biopharmaceuticals ltd, israel - venetoclax - טבליות מצופות פילם - venetoclax 50 mg - venetoclax
טבליס 100 מג
medison pharma ltd - fostamatinib as disodium hexahydrate - טבליות מצופות פילם - fostamatinib as disodium hexahydrate 100 mg - fostamatinib
טבליס 150 מג
medison pharma ltd - fostamatinib as disodium hexahydrate - טבליות מצופות פילם - fostamatinib as disodium hexahydrate 150 mg - fostamatinib
וומריטי 231 מג
medison pharma ltd - diroximel fumarate - diroximel fumarate 231 mg
קונבניה וטרינרי
zoetis israel holding b.v., israel - cefovicin as sodium salt - אבקה וממס להכנת תמיסה להזרקה - cefovicin as sodium salt 80 mg/dose - dogs : for the treatment of skin and soft tissue infections including pyoderma wounds and abscesses associated with staphylococcus intermedius beta-haemolytic streptococci escherichia coli and/or pasteurella multocida. for the treatment of urinary tract infections associated with escherichia coli and/or proteus spp.as adjunctive treatment to mechanical or surgical periodontal therapy of severe infections of the gingival and periodontal tissues associated with porphyromonas spp. and prevotella spp. cats : for the treatment of skin and soft tissue abscesses and wounds associated with pasteurella multocida fusobacterium spp. bacteroides spp. prevotella oralis beta-haemolytic streptococci and/or staphylococcus intermedius. for the treatment of urinary tract infections associated with escherichia coli.
סוטנט 12.5 מג
pfizer pharmaceuticals israel ltd - sunitinib as malate - קפסולות - sunitinib as malate 12.5 mg - sunitinib - sunitinib - sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sutent is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.
סוטנט 25 מג
pfizer pharmaceuticals israel ltd - sunitinib as malate - קפסולות - sunitinib as malate 25 mg - sunitinib - sunitinib - sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sutent is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.